Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jun;45(6):268-71.
doi: 10.1007/BF02280989.

Role of endotoxin-like contaminants in the apparent anti-inflammatory activity of bovine superoxide dismutase

Affiliations

Role of endotoxin-like contaminants in the apparent anti-inflammatory activity of bovine superoxide dismutase

M Iida et al. Inflamm Res. 1996 Jun.

Abstract

Bovine CuZn superoxide dismutase (SOD: 1, 3 and 10 mg/kg) dose-dependently reduced carrageenan-induced paw edema in rats when administered intravenously 30 min before irritant injection. However, heat-treated SOD (10 mg/kg) was as effective as native SOD (10 mg/kg) although the enzymic activity was reduced to 9.7%. Examination of the contaminants of the native SOD revealed a fairly large amount of endotoxin-like activity, 47 ng as Escherichia coli endotoxin per mg, and 59.6% of this activity remained after heat treatment. Bovine CuZn SOD (1, 3 and 10 mg/kg), which contained negligible endotoxin-like materials and 1.5 times more enzyme units, had no effect on edema under the same conditions. Furthermore, Escherichia coli endotoxin (10, 100 and 1000 ng/kg) reduced edema dose-dependently. These results suggest that contamination by endotoxin-like materials is responsible for the anti-inflammatory action of the SOD preparation we observed. Hence, the anti-inflammatory action of contaminating endotoxin-like materials may lead to misinterpretation as a protective effect of SOD unless stringent precautions are taken against endotoxin-like contaminants in the SOD under examination.

PubMed Disclaimer

Similar articles

References

    1. J Pharm Pharmacol. 1977 Nov;29(11):702-4 - PubMed
    1. Biol Signals. 1993 Jan-Feb;2(1):37-44 - PubMed
    1. Yale J Biol Med. 1983 Jul-Aug;56(4):293-301 - PubMed
    1. Arzneimittelforschung. 1979;29(5):781-5 - PubMed
    1. Infect Immun. 1985 Nov;50(2):527-33 - PubMed

MeSH terms

LinkOut - more resources